BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 25893930)

  • 1. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS; Morton R; Barnette G; Sieber P; Hancock ML; Steiner M
    J Clin Oncol; 2013 Feb; 31(5):523-9. PubMed ID: 23295793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
    Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
    Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial.
    Morgia G; Voce S; Palmieri F; Gentile M; Iapicca G; Giannantoni A; Blefari F; Carini M; Vespasiani G; Santelli G; Arnone S; Pareo RM; Russo GI
    Phytomedicine; 2017 Oct; 34():1-5. PubMed ID: 28899491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
    Bunker CH; McDonald AC; Evans RW; de la Rosa N; Boumosleh JM; Patrick AL
    Nutr Cancer; 2007; 57(2):130-7. PubMed ID: 17571945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
    Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K; Li X; Du Y; Tang X; Arai S; Geng Y; Xi Y; Xu H; Zhou Y; Ma W; Zhang T
    Oncotarget; 2017 May; 8(22):36674-36684. PubMed ID: 28415774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia.
    Joniau S; Goeman L; Roskams T; Lerut E; Oyen R; Van Poppel H
    Urology; 2007 Jun; 69(6):1102-6. PubMed ID: 17572195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
    Mohanty NK; Saxena S; Singh UP; Goyal NK; Arora RP
    Urol Oncol; 2005; 23(6):383-5. PubMed ID: 16301113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial.
    Micali S; Territo A; Pirola GM; Ferrari N; Sighinolfi MC; Martorana E; Navarra M; Bianchi G
    Arch Ital Urol Androl; 2017 Oct; 89(3):197-202. PubMed ID: 28969404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.
    Bettuzzi S; Brausi M; Rizzi F; Castagnetti G; Peracchia G; Corti A
    Cancer Res; 2006 Jan; 66(2):1234-40. PubMed ID: 16424063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
    Fleshner NE; Kapusta L; Donnelly B; Tanguay S; Chin J; Hersey K; Farley A; Jansz K; Siemens DR; Trpkov K; Lacombe L; Gleave M; Tu D; Parulekar WR
    J Clin Oncol; 2011 Jun; 29(17):2386-90. PubMed ID: 21537051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
    Milonas D; Auskalnis S; Skulcius G; Gudinaviciene I; Jievaltas M; Joniau S
    World J Urol; 2017 May; 35(5):721-728. PubMed ID: 27644229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.
    Kumar NB; Pow-Sang J; Egan KM; Spiess PE; Dickinson S; Salup R; Helal M; McLarty J; Williams CR; Schreiber F; Parnes HL; Sebti S; Kazi A; Kang L; Quinn G; Smith T; Yue B; Diaz K; Chornokur G; Crocker T; Schell MJ
    Cancer Prev Res (Phila); 2015 Oct; 8(10):879-87. PubMed ID: 25873370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
    Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
    Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
    Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
    Clark LC; Marshall JR
    Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of widespread high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: should we rebiopsy them all?
    Oderda M; Rosazza M; Agnello M; Barale M; Calleris G; Daniele L; Delsedime L; Falcone M; Faletti R; Filippini C; Giordano A; Marquis A; Marra G; Pacchioni D; Gontero P
    Scand J Urol; 2021 Apr; 55(2):129-134. PubMed ID: 33410348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II Randomized Trial of Lycopene-Rich Tomato Extract Among Men with High-Grade Prostatic Intraepithelial Neoplasia.
    Gann PH; Deaton RJ; Rueter EE; van Breemen RB; Nonn L; Macias V; Han M; Ananthanarayanan V
    Nutr Cancer; 2015; 67(7):1104-12. PubMed ID: 26422197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.